(Q42604697)

3 November 2017

Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis (English)

1 reference

3 November 2017

3

D Ross-Degnan

1 reference

3 November 2017

A Cameron

1

1 reference

3 November 2017

M Ewen

series ordinal

2

1 reference

3 November 2017

D Ball

series ordinal

4

1 reference

3 November 2017

R Laing

series ordinal

5

1 reference

3 November 2017

language of work or name

English

0 references

publication date

29 November 2008

1 reference

3 November 2017

1 reference

3 November 2017

373

1 reference

3 November 2017

9659

1 reference

3 November 2017

240-249

1 reference

Methodological aspects of international drug price comparisons

3 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961762-6

7 January 2021

The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961762-6

7 January 2021

The pricing and procurement of antiretroviral drugs: an observational study of data from the Global Fund

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961762-6

7 January 2021

International price comparisons for pharmaceuticals. Measurement and policy issues

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961762-6

7 January 2021

Price differentiation and transparency in the global pharmaceutical marketplace.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961762-6

7 January 2021

Diabetes care in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961762-6

7 January 2021

10.1016/S0140-6736(08)61762-6

Identifiers

DOI

1 reference

3 November 2017

1 reference